Connectyx Announces Donald T. Locke Joins Connectyx Board of Directors.

PALM CITY, Fla. -- Ronn Schuman, CEO of Connectyx Technologies (Pink Sheets:CTYX), announced today that Donald T. Locke, Connectyx's Legal Counsel, has accepted the position of Director and Secretary. "Mr. Locke has over 20 years of experience in public company finance, acquisitions and reporting, which will be a strong addition to the company's board of directors. Mr. Locke formerly served as the Chief Financial Officer and Executive Vice-President-Corporate Development of Oasys Mobile, Inc., a publicly traded company which developed and distributed applications for wireless devices. Prior to his work with Oasys Mobile, Mr. Locke was Of Counsel to Kilpatrick Stockton LLP, a large southeastern law firm, where his practice focused on public company finance and reporting, mergers and acquisitions and Securities and Exchange Commission issues. Mr. Locke received his bachelor's degree from Furman University in 1980 and his Masters of Business Administration and Law degrees from the University of South Carolina in 1986 and 1987," stated Ronn Schuman.

Donald Locke stated, "I look forward to working with Mr. Schuman and the rest of the Board at Connectyx to help them advance their business plan. Connectyx has cutting edge products in an area that is becoming of great importance, the management of personal health information."

About Connectyx

Connectyx Technologies is a publicly held company that provides business and consumer intelligent software, which provides technical excellence, innovation, and performance.

www.connectyx.com, www.mrnmanager.com, www.med-flash.com

This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, rules and regulations promulgated under the Act, unanticipated changes in Medicare reimbursement, outcomes of government reviews, inquiries and investigations and related litigation, continued compliance with government regulations, fluctuations in customer demand, management of rapid growth, competition from other healthcare product vendors, timing and acceptance of new product introductions, general economic conditions, geopolitical events and regulatory changes, as well as other relevant risks. The information set forth herein should be read in light of such risks. Connectyx assumes no obligation to update the information contained in this press release.